Curaleaf Holdings (CURLF) Total Current Liabilities (2019 - 2025)

Curaleaf Holdings (CURLF) recorded quarterly Total Current Liabilities of $294.3 million in Q4 2025, down 24.13% quarter-over-quarter from $387.9 million in Q4 2024, and down 24.13% on a YoY basis from $387.9 million in Q4 2024.

Curaleaf Holdings (CURLF) Total Current Liabilities (2019 - 2025) Analysis & Trends

Curaleaf Holdings' Total Current Liabilities history runs 7 years deep, the most recent figure standing at $294.3 million for Q4 2025.

  • In Q4 2025, Total Current Liabilities fell 24.13% year-over-year to $294.3 million; the TTM figure through Dec 2025 stood at $294.3 million (down 24.13% YoY), while the FY2025 annual figure was $294.3 million, down 24.13% from the prior year.
  • Total Current Liabilities was $294.3 million for Q4 2025 at Curaleaf Holdings, down from $387.9 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $436.8 billion in Q1 2022 to a low of $215.3 million in Q2 2021.
  • Historically, Total Current Liabilities has averaged $31.6 billion across 5 years, with a median of $385.3 million in 2022.
  • The sharpest annual moves came in 2022 and 2024: Total Current Liabilities surged 183454.65% in 2022, then slumped 31.81% in 2024.
  • A 5-year view of Total Current Liabilities shows it stood at $316.2 million in 2021, then surged by 38.16% to $436.9 million in 2022, then grew by 13.07% to $494.0 million in 2023, then decreased by 21.48% to $387.9 million in 2024, then decreased by 24.13% to $294.3 million in 2025.
  • The last three Total Current Liabilities figures came in at $294.3 million (Q4 2025), $387.9 million (Q4 2024), and $379.3 million (Q3 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 13.53 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 2.05 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 599.10 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 831.70 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 1.66 Bn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 599.50 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 333.17 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 618.78 Mn
10 Curaleaf Holdings - - 157.29 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 294.31 Mn
Dec 31, 2024 387.93 Mn
Sep 30, 2024 379.26 Mn
Jun 30, 2024 392.51 Mn
Dec 31, 2023 494.03 Mn
Sep 30, 2023 556.21 Mn
Jun 30, 2023 515.88 Mn
Sep 30, 2022 436.92 Mn
Jun 30, 2022 382.65 Mn
Mar 31, 2022 436.81 Bn
Dec 31, 2021 316.24 Mn
Sep 30, 2021 335.21 Mn
Jun 30, 2021 215.35 Mn
Mar 31, 2021 237.97 Mn
Dec 31, 2020 220.13 Mn
Sep 30, 2020 177.15 Mn
Dec 31, 2019 106.26 Mn